Pandemic pricing: existing drugs and price gouging

Biologics Laboratory
For existing medicines and technologies being trialled against Covid-19, prices are being scrutinised across the supply chain to prevent exploitative price-gouging during a period of surging demand. Photographer: Mikael Sjoberg/Bloomberg